Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national blog main
national top stories
2
×
new york blog main
new york top stories
pfizer
san diego blog main
san diego top stories
abbvie
adverum biotechnologies
akcea therapeutics
albert bourla
alzheimer's disease
amgen
amicus therapeutics
anylam pharmaceuticals
arvinas
batten disease
bayer
biogen
biotech
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
cancer diagnostics
cancer immunotherapy
cardiomyopathy
casimir trials
celenex
christine mcsherry
chuck schumer
clinial trials
clinical trials
crispr therapeutics
cystic fibrosis
dan chevallard
darolutamide
What
drug
2
×
patients
pfizer
2
×
acquisitions
ago
akcea
albert
alnylam
amyloidosis
approved
attr
available
battle
biggest
bio
bourla
ceo
company
crispr
debilitating
disease
fda
future
genetic
imports
maker
maps
measured
medicines
oks
pfizer’s
rare
revenue
roundup
sets
today
transthyretin
world’s
year
Language
unknown
Current search:
pfizer
×
drug
×
" national top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
